Ken Macnamara joined AskBio in 2019 with a wealth of R&D, business operations, financial planning, intellectual property and quality/compliance experience gained from start-up to multinational firms. He most recently was Chief Operating Officer at Synpromics.

Dr. Macnamara began his career at the University of Edinburgh, where he earned a PhD in chemistry before helping to start Lab901 (Scottish SME). There, he was a product development manager responsible for developing the TapeStation and ScreenTape technologies from concept to market success. Lab901 was acquired by Agilent Technologies in 2011. Dr. Macnamara then served as R&D director for the Microfluidics Business at Agilent, taking responsibility for setting the R&D strategy and leading the team through tremendous business growth.